Division of Cardiothoracic Surgery, Saint Louis University School of Medicine, 1008 South Spring Avenue, Saint Louis, MO 63110, USA.
Division of Cardiothoracic Surgery, Saint Louis University School of Medicine, 1008 South Spring Avenue, Saint Louis, MO 63110, USA.
Thorac Surg Clin. 2021 May;31(2):107-118. doi: 10.1016/j.thorsurg.2021.01.004.
The National Emphysema Treatment Trial compared medical treatment of severe pulmonary emphysema with lung-volume-reduction surgery in a multiinstitutional randomized prospective fashion. Two decades later, this trial remains one of the key sources of information we have on the treatment of advanced emphysematous lung disease. The trial demonstrated the short- and long-term effectiveness of surgical intervention as well as the need for strict patient selection and preoperative workup. Despite these findings, the key failure of the trial was an inability to convince the medical community of the value of surgical resection in the treatment of advanced emphysema.
国家肺气肿治疗试验(National Emphysema Treatment Trial)以多机构、随机、前瞻性的方式比较了严重肺气肿的内科治疗与肺减容手术治疗。二十年后,该试验仍然是我们在治疗晚期肺气肿疾病方面的重要信息来源之一。该试验证明了手术干预的短期和长期效果,以及严格的患者选择和术前评估的必要性。尽管有这些发现,但该试验的主要失败之处在于未能使医学界相信手术切除在治疗晚期肺气肿方面的价值。